Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595795 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| cGAS in nucleus: The link between immune response and DNA damage repair. | Front Immunol | 2022 | 36591232 | PubTator, text mining | PubMed |
| SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. | Breast Cancer Res | 2022 | 36581908 | PubTator, text mining | PubMed |
| Apoptosis regulation by the tyrosine-protein kinase CSK. | Front Cell Dev Biol | 2022 | 36578781 | PubTator, text mining | PubMed |
| Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options. | J Pers Med | 2022 | 36573710 | PubTator, text mining | PubMed |
| Identification of key genes in late-onset major depressive disorder through a co-expression network module. | Front Genet | 2022 | 36561317 | PubTator, text mining | PubMed |
| SH2 Domains: Folding, Binding and Therapeutical Approaches. | Int J Mol Sci | 2022 | 36555586 | PubTator, text mining | PubMed |
| Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis. | Int J Mol Sci | 2022 | 36555115 | PubTator, text mining | PubMed |
| B Cells at the Cross-Roads of Autoimmune Diseases and Auto-Inflammatory Syndromes. | Cells | 2022 | 36552788 | PubTator, text mining | PubMed |
| Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective. | Biomedicines | 2022 | 36552035 | PubTator, text mining | PubMed |
| A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors. | Curr Oncol | 2022 | 36547158 | PubTator, text mining | PubMed |
| An overview of PROTACs: a promising drug discovery paradigm. | Mol Biomed | 2022 | 36536188 | PubTator, text mining | PubMed |
| Identification of Key Genes from the Visceral Adipose Tissues of Overweight/Obese Adults with Hypertension through Transcriptome Sequencing. | Cytogenet Genome Res | 2022 | 36521430 | PubTator, text mining | PubMed |
| Association of single nucleotide polymorphism rs113420705 of CASP3 in children with Kawasaki disease from North India. | J Family Med Prim Care | 2022 | 36505637 | PubTator, text mining | PubMed |
| Natural Products as Anticancer Agents: Current Status and Future Perspectives. | Molecules | 2022 | 36500466 | PubTator, text mining | PubMed |
| The Role of Epigenetics in Neuroinflammatory-Driven Diseases. | Int J Mol Sci | 2022 | 36499544 | PubTator, text mining | PubMed |
| Lupus Nephritis: Current Perspectives and Moving Forward. | J Inflamm Res | 2022 | 36483271 | PubTator, text mining | PubMed |
| Acute haemothorax secondary to ibrutinib: A case report. | EJHaem | 2022 | 36467786 | PubTator, text mining | PubMed |
| Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database. | Front Pharmacol | 2022 | 36438789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=17